Founded by Andre Watson after more than a decade of nanotechnology and bioengineering R&D, Ligandal develops AI-designed peptide and nanoparticle delivery technology for precision medicine. Its peptide-directed conjugate platform targets cellular receptors and delivers payloads such as nucleic acids or gene-editing therapies to intended cells, while the LigandAI™ platform supports computational peptide design and binding analysis. The company’s focus is solving the delivery challenge that limits molecularly targeted treatments.
Nanobrid Innovations Private LimitedNanobrid Innovations Private Limited is an Indian nanotechnology company developing formulation solutions for drug delivery. Its proprietary Nanobrid® platform is intended to help deliver difficult-to-formulate active ingredients more effectively and conveniently for patients.RAJASTHAN, IN
Congruence Medical Solutions LLCBaltimore-based Congruence Medical Solutions designs, develops and supplies drug-delivery devices that add precision and usability to standard prefillable syringes and other primary containers. The company is especially known for its award-winning Microliter Dosing Syringe, developed for difficult small-volume injections and recognized with the 2019 PDA Drug Delivery Innovation Award in partnership with Santen Pharmaceutical. Its platforms also address viscous and variable-dose therapies, home injection, and drug waste from vials, including through the ELDO™ technology selected for the Johnson & Johnson Innovation–JLABS and BARDA BLUE KNIGHT program.BALTIMORE, MD
Facili Bio LLCFacili Bio LLC uses an AI-powered drug-discovery platform and proprietary computational biology to develop new cancer treatments. The company focuses on difficult areas of oncology, pairing research into patient-specific therapies with clinical studies intended to move promising discoveries toward patients.ALBANY, NY
Aquavit Pharmaceuticals, IncFounded in New York City in 2010, Aquavit Pharmaceuticals is a biotechnology company known for developing personalized healthcare through modern drug-delivery systems. Its patented micro-channel platform is designed to deliver therapeutic agents directly into the skin, supporting more targeted treatment while minimizing systemic toxicity. Aquavit has commercialized AQUAGOLD® and maintains an intellectual-property portfolio of more than 30 patents and 25 trademarks.NEW YORK, NY